(Q37209122)

19 August 2017

1 reference

title

How to predict and prevent the immunogenicity of therapeutic proteins (English)

1 reference

19 August 2017

Huub Schellekens

1

1 reference

19 August 2017

1 January 2008

1 reference

Biotechnology Annual Review

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

191-202

1 reference

Pharmaceutical biotechnology products approved within the European Union

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Role of aggregated human growth hormone (hGH) in development of antibodies to hGH

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Immunogenicity of therapeutic proteins: clinical implications and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Bioequivalence and the immunogenicity of biopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

The influence of antigen organization on B cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Role of repetitive antigen patterns for induction of antibodies against antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

PEGylation, successful approach to drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Antibody Response to Aggregated Human Interferon Alpha2b in Wild-type and Transgenic Immune Tolerant Mice Depends on Type and Level of Aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Effects of protein aggregates: an immunologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Development of a transgenic mouse model immune tolerant for human interferon Beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

Engineering of therapeutic antibodies to minimize immunogenicity and optimize function

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2808%2900007-0

7 January 2021

10.1016/S1387-2656(08)00007-0

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18606364